BioWorld

Dec. 2, 2010

NewCo News: Acylin Pharma Explores 'Blooming' Acetylation Field

Germany's SuppreMol Raises $20.3M, Secures Path to 2013

Clinic Roundup

Stock Movers

Other News To Note

Axcan Agrees to Acquire Eurand in $583M Deal

Axcan Holdings Inc. will acquire Eurand NV for $12 per share in cash, a $583 million transaction that the companies expect to close in the second quarter of 2011. (BioWorld Today) Read More

Bayh-Dole Brought Shelved Inventions to Marketplace

Today's news in brief

BioWorld

BioWorld briefs for Dec. 17, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 17, 2024.

Second insulin receptor offers new therapeutic avenues

BioWorld Science

Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...

Drug duo to Repare lack in gyno cancers? Phase I shows promise

BioWorld

Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

Mechanism underlying so-called idiopathic autism inception unveiled

BioWorld Science

Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...